These results suggested that low expression of ADAM12 may inhibit the proliferation of hepatoma cells by suppressing cell cycle progression, further suggesting that the ADAM12 gene is related to poor prognosis in HCC. This evidence concerns the gene ADAM12 and hepatocellular carcinoma.